CNN Exclusive: Older weight loss drugs are making a comeback as Zepbound, Wegovy remain out of reach for many

Resurgence of Interest: The article highlights a resurgence in interest regarding older weight loss drugs.

Ongoing Obesity Epidemic: Researchers are revisiting these drugs due to the persistent obesity epidemic and its associated health issues.

Reevaluation of Effectiveness: Phentermine and orlistat, both available for decades, are being reevaluated for their effectiveness in weight management.

Safety Considerations: The safety of these medications is a key focus of the reevaluation.

Addressing Rising Health Concerns: The article underscores the importance of finding effective ways to address the increasing health concerns related to obesity.